# Filing Detail

Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001178913-25-002298
Filing Date
2025-07-02
Accepted
2025-07-02 16:17:35
Documents
2

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 424B3 | zk2533410.htm | 424B3 | 330355
2 |  | image0.jpg | GRAPHIC | 584332
| Complete submission text file | 0001178913-25-002298.txt |  | 1136083

Mailing Address 21 HA'ARBA'A STREET TEL AVIV L3 64739
Business Address 21 HA'ARBA'A STREET TEL AVIV L3 64739 972-3-541-3131
RedHill Biopharma Ltd. (Filer) CIK: 0001553846 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3
Type: 424B3 | Act: 33 | File No.: 333-288324 | Film No.: 251101312
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)